# Adaptive Gene Expression Induced by a Combination of IL-1β and LPS in Primary Cultures of Mouse Astrocytes

**Authors:** Thierry Coppola, Gwénola Poupon, Hélène Rangone, Stéphane Martin, Patricia Lebrun

PMC · DOI: 10.3390/cells14211737 · 2025-11-05

## TL;DR

This study shows how mouse astrocytes adapt their gene expression in response to chronic inflammation caused by IL-1β and LPS, affecting key metabolic processes.

## Contribution

The study identifies reversible adaptive gene expression changes in astrocytes under chronic inflammation, focusing on glutamate and lactate metabolism.

## Key findings

- Upregulation of the glutamate transporter eaat2 leads to glutamate accumulation and altered glutamate-glutamine cycling.
- Increased glycolytic activity and lactate production/export via hk1, hk2, and mct4 are observed.
- Adaptive mechanisms are reversible, suggesting a controlled response to stress.

## Abstract

Astrocytes are vital cells within the central nervous system (CNS), as they perform a critical role in supporting neurons by providing nutrients, such as lactate for energy, and safeguarding them against the toxicity of excessive neurotransmitters, such as glutamate. This study investigates astrocyte adaptive mechanisms in response to chronic inflammation. The primary aim is to assess the long-term effects of an inflammation-induced environment using a combination of lipopolysaccharide (LPS) and interleukin-1β (IL-1β), on the expression of key genes involved in essential metabolic pathways for astrocyte function, including glutamate metabolism and clearance, lactate synthesis and transport, and glucose metabolism. We observed an upregulation of the glutamate transporter eaat2 (but not eaat1), leading to glutamate accumulation and altered glutamate-glutamine cycling, as well as increased glycolytic activity and lactate production/export via hexokinases (hk1 and hk2) and the mct4 lactate transporter. Interestingly, these mechanisms are reversible, indicating a precisely controlled adaptive system. This investigation facilitated the identification of the signaling pathways involved in astrocyte adaptive responses to stress. This will further guide our investigations towards the more complex domain of resistance and adaptation of CNS in pathophysiological conditions.

## Linked entities

- **Genes:** SLC1A2 (solute carrier family 1 member 2) [NCBI Gene 6506], SLC1A3 (solute carrier family 1 member 3) [NCBI Gene 6507], HK1 (hexokinase 1) [NCBI Gene 3098], HK2 (hexokinase 2) [NCBI Gene 3099], SLC16A4 (solute carrier family 16 member 4) [NCBI Gene 9122]
- **Proteins:** IL1B (interleukin 1 beta), IRF6 (interferon regulatory factor 6)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Slc1a3 (solute carrier family 1 (glial high affinity glutamate transporter), member 3) [NCBI Gene 20512] {aka B430115D02Rik, Eaat1, GLAST, GLAST-1, GLU-T, GluT-1}, Slc1a2 (solute carrier family 1 (glial high affinity glutamate transporter), member 2) [NCBI Gene 20511] {aka 1700091C19Rik, 2900019G14Rik, Eaat2, GLT-1, GLT1, MGLT1}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, Hk2 (hexokinase 2) [NCBI Gene 15277] {aka HKII}, Hk1 (hexokinase 1) [NCBI Gene 15275] {aka Hk-1, Hk1-s, dea, mHk1-s}
- **Diseases:** chronic (MESH:D002908), inflammation (MESH:D007249), toxicity (MESH:D064420)
- **Chemicals:** glucose (MESH:D005947), lactate (MESH:D019344), glutamate (MESH:D018698), glutamine (MESH:D005973), LPS (MESH:D008070)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12610311/full.md

---
Source: https://tomesphere.com/paper/PMC12610311